Health TrialsbyHealthPanel

Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

ConditionBehcet Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-17
SponsorCairo University

About this trial

physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adlescent patients

complain Behcet disease

after pulmonary endoarterectomy

Disqualifiers

chronci cardiac diseases

psychic disease

mental disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • inspiratory muscle trianing

    Other intervention

    twenty Behcet disease patients with pulmonary endoarterectomy will be will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week)

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: group number 1Experimental treatment 1 intervention
Group B: group number 2No intervention 0 interventions

Trial outcomes

Primary outcomes

1

forced vital capacity

it si a pulmaonry fucntion test

Time frame
it will be measured after 12 weeks

Secondary outcomes

1

forced expiratory volume

it will be assessed in first second of expiration

Time frame
It will be measured after 12 weeks
2

ratio of force vital capcity to first-second-expiratory forced expiration volume

it is a pulmoanry fucntion test

Time frame
It will be measured after 12 weeks
3

fatigue severity scale

it will assess fatigue perception

Time frame
It will be measured after 12 weeks
4

child health questainanire parent form assessment of phsyical summary

it is an assessment of quality of life

Time frame
it will be measured after 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov
Apply now